Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q1 2022 · 10-Q
Revenue$16.12M$16.12M+4.2% vs Q1 2021 Net Income-$7.16M-$7.16MN/M vs Q1 2021 EPS Diluted-$0.84-$0.84N/M vs Q1 2021 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flow-$9,811,000N/M Margins · derivedGross margin-4.9%−7.5 pt vs Q1 2021
Operating margin-41.1%+5.3 pt vs Q1 2021
Net margin-44.4%+5.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end